JW Holdings to export COVID-19 treatment antibiotics to Luxembourg, South Africa
JW Holdings to export COVID-19 treatment antibiotics to Luxembourg, South Africa
  • Kim Min-jee
  • 승인 2020.05.15 11:00
  • 댓글 0
이 기사를 공유합니다

JW Levofloxacin Inj. (left) and JW Prepenem (right)

JW Holdings will urgently export antibiotics used for treatment of patients infected with COVID-19 to Luxembourg and South Africa, a company spokesman said on May 14.

The product exported to Luxembourg is JW Levofloxacin Inj. (component: levofloxacin), a quinolone antibiotic that is effective in respiratory and sinusitis. Unlike ordinary injections, levofloxacin is mixed with saline, so it is a pre mixture sap using without a separate dilution process.

The emergency drug supply was made at the request of Luxembourg's representative in Korea. The company plans to export the drug on May 19.

In addition, JW Holdings won a large-scale emergency bid conducted by the South African government in collaboration with local trading company Austell Laboratories as demand for Carbapenem-based antibiotics soared in South Africa.

By doing so, the company will supply twice the amount of Prepenem inject. (main ingredient: imipenem) that it has contracted annually.

Prepenem injection is the world's first generic of imipenem developed by JW Pharmaceutical in 2004 and is used to treat severe infections such as pneumonia and abdominal infections.

An official from JW Holdings said, "The demand for antibiotics for the treatment of severe patients is rapidly increasing in the situation of COVID-19 Pandemic," and added, "We will make efforts to expand exports to countries that are having difficulty supplying antibiotics, a typical emergency medicine."

Meanwhile, JW Pharmaceutical has gained global competitiveness in the field of carbapenem-based antibiotics since it succeeded in developing the world's first generic imipenem.

Starting with imipenem, JW Pharmaceutical has a factory dedicated to raw material synthesis in Sihwa and a factory for finished products in Dangjin and is using it as an overseas export base.

삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • URL: www.koreaittimes.com / m.koreaittimes.com. Editorial Div. 02-578-0434 / 010-2442-9446. Email: info@koreaittimes.com.
  • Publisher: Monica Younsoo Chung. Chief Editorial Writer: Kim Hyoung-joong. CEO: Lee Kap-soo. Editor: Jung Yeon-jin.
  • Juvenile Protection Manager: Yeon Choul-woong. IT Times Canada: Willow St. Vancouver BC, Canada / 070-7008-0005.
  • Copyright(C) Korea IT Times, Allrights reserved.